Rolling Out15h
How a sleep mask for apnea reduces high blood pressure risk
Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
pulmonologyadvisor1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
Knowridge17h
Innovative drug therapy can effectively treat sleep apnea
Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
CNBC on MSN20d
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...
Everyday Health13d
FDA Approves First Medication for Obstructive Sleep Apnea
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
Future Market Insights2d
Global Continuous Positive Airway Pressure (CPAP) Market Poised for Sustained Growth, Reaching USD 900 Million by 2033 rise at a CAGR of 6%
The global continuous positive airway pressure (CPAP) market is projected to reach a value of USD 900 million by 2033, ...
Medscape17d
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
Until now, OSA treatment has focused on mechanical support during sleep in the form of positive airway pressure (PAP) therapy. "Today's approval marks the first drug treatment option for certain ...